Impact of Lipophilic Efficiency
on Compound Quality
- Publication date
- Publisher
Abstract
Lipophilic efficiency indices such as LLE and LELP were
suggested
to support balanced optimization of potency and ADMET profile. Here
we investigated the performance of LLE and LELP on multiple data sets
representing different stages of drug discovery including fragment
and HTS hits and leads, development candidates, phase II compounds,
and launched drugs. Analyzing their impact on ADME and safety properties
and binding thermodynamics, we found that both LLE and LELP help identifying
better quality compounds. LLE is sensible for the development stages
but does not prefer fragment-type hits, while LELP has an advantage
for this class of compounds and discriminates preferred starting points
effectively. Both LLE and LELP have significant impact on ADME and
safety profiles; however, LELP outperforms LLE in risk assessment
at least on the present data set. On the basis of the results reported
here, monitoring lipophilic efficiency metrics could contribute significantly
to compound quality and might improve the output of medicinal chemistry
programs